JUN 25, 2019 10:00 PM PDT

Scientists use AI to reveal an unexpected role for "junk" DNA in autism

According to a new study published in Nature Genetics, spontaneous mutations or "junk" DNA that occur between genes may turn out to be key to understanding autism. This study was the first to examine the impact of these 'noncoding' mutations across the entire genome of autistic individuals.

Over the past three years, several research teams have sequenced the DNA of autistic people both within and between genes. However, sorting through thousands and thousands of mutations between genes has proved extremely challenging.

In a recent study led by Princeton professor Olga Troyanskaya, deputy director for genomics at the Flatiron Institute's Center for Computational Biology in New York City, and collaborators researchers overcame this challenge by using artificial intelligence (AI) deep learning to identify the contribution of noncoding mutations to autism risk.

In the study, scientists created an algorithm to predict whether a certain noncoding mutation alters any gene's expression. The algorithm assigns each mutation a score which indicates how likely it is to alter gene expression, and therefore, how harmful it is.

The study is particularly strong because it examines spontaneous mutations across the whole genome.

Prior effects tend to analyze noncoding mutations within a certain region of the genome, typically those closest to the gene of interest, says professor Xin He, assistant professor of genetics at the University of Chicago, who was not involved in the study.

Troyanskaya's team and her colleagues analyzed 7,097 whole genomes from 1,790 families that have one autistic child but normal parents and at least one unaffected sibling. They found thousands of spontaneous mutations in the autistic children, but approximately the same number in unaffected children.

Then, the team searched through the Human Gene Mutation Database to check whether the mutations had known links to medical conditions or appeared in healthy individuals. They gathered all of this information to generate an impact score for each mutation.

Researchers found that noncoding mutations in children with autism had greater impact cores than those of their unaffected siblings. Interestingly, in a follow-up study on the high-impact noncoding mutations in autistic children were expressed in brain tissue. Thus, the study may indicate that such noncoding regulatory elements in the developing brain may contribute to autism, as well as other neurodevelopmental disorders.

Now, Troyanskaya and her colleagues are applying the algorithm, called DeepSEA, to whole genomes of individuals with other medical conditions such as heart disease.

Source: Scientific American, Psychology Today

About the Author
You May Also Like
JUL 24, 2019
Neuroscience
JUL 24, 2019
Eye Contact Activates Brain Regions Involved in Social Behavior
Much of us already know that eye contact is very important when engaging someone in a conversation. But why exactly? A new study out of National Insti...
JUL 24, 2019
Health & Medicine
JUL 24, 2019
Why Scientists are Growing Brains in Petri Dishes
  Scientists now have a method for growing an active brain from skin cells. Previously, scientists were able to generate stem cells from undeveloped s...
JUL 24, 2019
Plants & Animals
JUL 24, 2019
Kakapo Parrot Chick Undergoes Life-Saving Brain Surgery
The kakapo parrot (Strigops habroptilus), recognized by the International Union for Conservation of Nature (IUCN) as a critically-endangered species on the...
JUL 24, 2019
Drug Discovery
JUL 24, 2019
Miracle Drug for Rare Genetic Disease Causes Price Concerns
A newly approved “miracle drug” called Zolgensma will be used to treat children with spinal muscular atrophy, or SMA. Unfortunately, the therap...
JUL 24, 2019
Drug Discovery
JUL 24, 2019
Anticholinergic Drugs and Dementia?
A link between anticholinergic drug use and cognitive impairment was recently observed from observational studies on randomized clinical trials. Regenstrie...
JUL 24, 2019
Drug Discovery
JUL 24, 2019
The Composition of Cerebrospinal Fluid in MS patients Could Be The Key To Treatments That Halt Progression
The range of disability for individuals living with multiple sclerosis (MS) varies significantly depending on the relapsing/remitting form of the disease....
Loading Comments...